Acute Pancreatitis Market is segmented By Treatment (Drug therapy, Supportive Care, Surgery), By End...
Market Size in USD Mn
CAGR4.7%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 4.7% |
Market Concentration | Medium |
Major Players | Takeda Pharmaceuticals, Novartis AG, Pfizer Inc., GlaxoSmithKline, AbbVie Inc. and Among Others |
The acute pancreatitis market is estimated to be valued at USD 547.1 Mn in 2025 and is expected to reach USD 754.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 4.7% from 2025 to 2032. The increasing incidence of gallstone diseases and alcohol consumption are major factors leading to the rise in number of acute pancreatitis cases. Acute pancreatitis poses a substantial disease burden worldwide with high rates of hospitalization and mortality.